Newron Pharmaceuticals S.p.A. (SWX:NWRN)

Newron Pharmaceuticals Revenue

Newron Pharmaceuticals had revenue of 3.19M EUR in the half year ending June 30, 2026, a decrease of -6.40%. This brings the company's revenue in the last twelve months to 10.42M, down -82.60% year-over-year. In the year 2025, Newron Pharmaceuticals had annual revenue of 19.13M, down -62.78%.

• Revenue (ttm): 10.42M EUR
• Revenue Growth: -82.60%
• P/S Ratio: 18.07
• Revenue / Employee: 385.81K EUR
• Employees: 27
• Market Cap: 173.73M CHF

Revenue Chart

Chart

Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	19.13M	-32.26M	-62.78%
Dec 31, 2024	51.39M	42.33M	467.41%
Dec 31, 2023	9.06M	2.96M	48.62%
Dec 31, 2022	6.09M	332.00K	5.76%
Dec 31, 2021	5.76M	504.00K	9.59%

Data Source: S&P Global Market Intelligence Last updated: Sep 22, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 2, 2026

Data Sources Report a data error